ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL3369 |
|
3922-90-5 |
Oleandomycin 98+% |
C35H61NO12 | |
HL1857 |
|
84955-05-5 |
Cudraxanthone B 98+% |
C23H22O6 | |
HL1855 |
|
140111-05-3 |
Thaxtomin C 96+% |
C21H20N4O4 | |
CLP1137 |
|
11140-99-1 |
Ristomycin Monosulfate | Ristocetin Sulfate salt | Ristomycin Sulfate 98+% |
C95H110N8O44.H2SO4 | |
CL2928 |
|
61379-65-5 |
Rifapentine | DL 473 | Cyclopentylrifampicin 98+% |
C47H64N4O12 | |
CL2441A |
|
56796-20-4 |
Cefmetazole | CS 1170 98+% |
C15H17N7O5S3 | |
CL1795A |
|
184539-13-7 |
Teicoplanin sodium | Antibiotic MDL-507 sodium | MDL-507 sodium
|
— | |
CL2710 |
|
80-08-0 |
Dapsone (DDS) 98+% |
C12H12N2O2S | |
CL2497 |
|
15893-52-4 |
2,4-Dihydroxy-7-methoxy-2H-benzo[b][1,4]oxazin-3(4H)-one; DIMBOA 98+% |
C9H9NO5 | |
HL1443 |
|
1740-19-8 |
Dehydroabietic acid 98+% |
C20H28O2 | |
CLA1332 |
|
1374419-41-6 |
Tosatoxumab 95+% |
— | |
CLA1219 |
|
896723-44-7 |
Farletuzumab (anti-FOLR1) 95+% |
— | |
CL1993 |
|
1397-89-3 |
Amphotericin B | NSC 527017 | LNS-AmB >750μg/mg |
C47H73NO17 | |
CL1971 |
|
119478-56-7 |
Meropenem Trihydrate (Synonyms: SM 7338 trihydrate) Purity: 99.08% |
C17H31N3O8S | |
CL1219 |
|
1000296-70-7 |
Sulopenem Etzadroxil (Synonyms: PF-03709270) 98+% |
C19H27NO7S3 | |
CL1227 |
|
56124-62-0 |
Valrubicin | AD-32 98+% |
C34H36F3NO13 | |
CL1108 |
|
57852-57-0 |
Idarubicin hydrochloride (Synonyms: Idarubicin HCl; 4-Demethoxydaunorubicin hydrochloride;4-demethoxydaunorubicin (NSC256439, 4-DMDR) HCl) 98+% |
C26H28ClNO9 | |
CL1228 |
|
56390-09-1 |
Epirubicin hydrochloride | Epirubicin HCl | IMI 28 HCl | NSC 256942 HCl | 4'-epidoxorubicin HCl 98+% |
C27H30ClNO11 | |
HL1044 |
|
501-36-0 |
Resveratrol | trans-Resveratrol | SRT501 99+% |
C14H12O3 | |
CL1118 |
|
117467-28-4 |
Cefditoren Pivoxil 98+% |
C25H28N6O7S3 | |